MGH Research Scholars Program
The MGH Research Scholars Program was established to support early career researchers with innovative yet unproven ideas that have the potential to transform the future of medicine. Funded 100% through philanthropy, this program gives researchers the freedom and flexibility they need to follow the science wherever it leads. History has shown that brilliant scientists who are given free rein to explore new frontiers make the greatest, often unexpected, advances.
The goal of the Ellisen Lab is to understand transcription factor deregulation as a means to therapeutically target and identify biomarkers of treatment response in a broad spectrum of human cancers.
The p53 Family of Transcription Factors in Development, Cancer Pathogenesis and Development
I am a basic and translational cancer researcher and practicing medical oncologist at the Massachusetts General Hospital Cancer Center, and an Associate Professor of Medicine at Harvard Medical School. I also direct the breast and ovarian cancer genetics program at Mass General.
The majority of my time is spent on basic research, the goal of which is to understand transcription factor deregulation as a means to therapeutically target and identify biomarkers of treatment response in a broad spectrum of human cancers.
As co-Executive Director of the Translational Research Laboratory (TRL) for tumor molecular profiling at the Mass General Cancer Center, our translational research focuses developing and implementing technologies for tumor molecular analysis to advance the goal of individualized cancer treatment.